Equities researchers at StockNews.com began coverage on shares of Milestone Scientific (NYSE:MLSS - Get Free Report) in a report issued on Friday. The firm set a "hold" rating on the stock.
Milestone Scientific Stock Performance
Shares of MLSS stock traded down $0.05 during trading on Friday, hitting $0.91. The company had a trading volume of 48,826 shares, compared to its average volume of 130,643. The stock's 50-day moving average price is $0.96 and its 200 day moving average price is $0.97. Milestone Scientific has a one year low of $0.58 and a one year high of $1.39. The firm has a market capitalization of $71.33 million, a P/E ratio of -13.00 and a beta of 0.93.
Hedge Funds Weigh In On Milestone Scientific
Several institutional investors have recently bought and sold shares of the company. Brookwood Investment Group LLC purchased a new position in Milestone Scientific in the 1st quarter worth $46,000. World Investment Advisors LLC bought a new position in Milestone Scientific during the third quarter valued at approximately $91,000. Renaissance Technologies LLC boosted its holdings in shares of Milestone Scientific by 72.8% in the fourth quarter. Renaissance Technologies LLC now owns 126,275 shares of the company's stock worth $121,000 after buying an additional 53,198 shares during the last quarter. Carnegie Investment Counsel grew its stake in shares of Milestone Scientific by 18.9% during the 4th quarter. Carnegie Investment Counsel now owns 172,609 shares of the company's stock valued at $166,000 after acquiring an additional 27,412 shares during the period. Finally, Geode Capital Management LLC raised its stake in Milestone Scientific by 6.4% during the 3rd quarter. Geode Capital Management LLC now owns 527,005 shares of the company's stock valued at $480,000 after purchasing an additional 31,572 shares during the period. Hedge funds and other institutional investors own 5.79% of the company's stock.
Milestone Scientific Company Profile
(
Get Free Report)
Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.
Featured Stories
Before you consider Milestone Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Milestone Scientific wasn't on the list.
While Milestone Scientific currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
